The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank

The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank

Abstract Background Chronic kidney disease (CKD) and non-alcoholic fatty liver disease (NAFLD) frequently co-exist. We assess the impact of having NAFLD on adverse clinical outcomes and all-cause mortality for people with CKD. Methods A total of 18,073 UK Biobank participants identified to have CKD...

Full description

Bibliographic Details
Main Authors: Theresa J. Hydes, Oliver J. Kennedy, Ryan Buchanan, Daniel J. Cuthbertson, Julie Parkes, Simon D. S. Fraser, Paul Roderick
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Medicine
Subjects:
Non-alcoholic fatty liver disease
Chronic kidney disease
Cardiovascular disease
Multi-morbidity
Online Access:https://doi.org/10.1186/s12916-023-02891-x

Internet

https://doi.org/10.1186/s12916-023-02891-x

Similar Items